Skip to main content
Clinical Trials/DRKS00032428
DRKS00032428
Recruiting
N/A

Treatment of psychiatric and neurocognitive sequelae of COVID-19 disease in adolescents and young adults

Klinikum Karlsbad Langensteinbach0 sites16 target enrollmentApril 18, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
F06.8
Sponsor
Klinikum Karlsbad Langensteinbach
Enrollment
16
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinikum Karlsbad Langensteinbach

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of psychiatric or cognitive disorders following an COVID\-19 infection (Post COVID syndrome)

Exclusion Criteria

  • \- no evidence of past infection with SARS\-CoV\-2
  • \- age under 15 or above 21 years

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
The cognition game studyCognitive impairment in psychiatric patients (we included subjects with schizophrenia/schizo-affective disorder, major depressive disorder and obsessive compulsive disorderMental and Behavioural Disorders
ISRCTN60175188MyCognition60
Completed
N/A
Cognitive remediation in psychiatric patients with an applied online cognitive game and assessment toolcognitive deficitspsychiatric disorders10009841
NL-OMON44811MyCognition80
Completed
N/A
Improved care for mental and neurological diseasesF30-F39F41.2F20-F29F43F00F01G30G35G20G21G22I63I64Mood [affective] disordersMixed anxiety and depressive disorderSchizophrenia, schizotypal and delusional disordersReaction to severe stress, and adjustment disordersDementia in Alzheimer diseaseVascular dementiaAlzheimer diseaseMultiple sclerosisParkinson diseaseSecondary parkinsonismParkinsonism in diseases classified elsewhereCerebral infarctionStroke, not specified as haemorrhage or infarction
DRKS00022754Kassenärztliche Vereinigung Nordrhein14,148
Active, Not Recruiting
Phase 4
Can extended treatment with N-pep-12 improve recovery after acute ischemic stroke?
ISRCTN15764675The Foundation for the Study of Neuroscience and Neuroregeneration (Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)107
Active, Not Recruiting
N/A
Supporting psychiatric treatment and therapy of unipolar depression through the use and application of health enabling technologiesF32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptoms
DRKS00022922Peter L. Reichertz Institut für Medizinische Informatikder TU Braunschweig und der Medizinischen Hochschule Hannover (PLRI)10